Stay updated on Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Sign up to get notified when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.

Latest updates to the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.5%
- Check8 days agoChange DetectedThe web page has been updated to a new version, v2.16.0, replacing the previous version v2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check44 days agoChange DetectedThe page has been updated to include new information about the Growth Hormone Disorder study, including a new registry identifier and a revision number. However, significant details about the study's methodology and inclusion criteria have been removed.SummaryDifference8%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check59 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
Stay in the know with updates to Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Somapacitan vs Placebo & Norditropin in GH Deficiency Clinical Trial page.